Patents by Inventor Martin Lotz

Martin Lotz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200009295
    Abstract: Provided herein is a scaffold comprising a decellularized meniscus tissue, wherein the scaffold is covalently conjugated with heparin and a growth factor. Also provided herein is a method of repairing and/or treating a tissue injury in a subject in need thereof, comprising: providing a scaffold comprising a decellularized meniscus tissue; and repairing and/or treating the tissue injury by implanting the scaffold over the tear, wherein the scaffold is covalently conjugated with heparin and a growth factor.
    Type: Application
    Filed: March 16, 2018
    Publication date: January 9, 2020
    Inventors: Martin Lotz, Kwang Il Lee
  • Patent number: 8309159
    Abstract: A process for producing coagulated leguminous protein fractions of MW>14, comprising: initial charging of fruit juice; coagulation of the leguminous protein; removal of a leguminous protein fraction whose majority has an MW of from >14 kD to approx. 600 kD; optionally, washing the coagulated leguminous protein fraction thus obtained; and optionally, drying the leguminous protein fraction, and to the use of the leguminous protein fraction as a food, food additive, medicament additive, animal feed, in cosmetics, as industrial protein, and/or as an adhesive.
    Type: Grant
    Filed: September 24, 2007
    Date of Patent: November 13, 2012
    Assignee: Emsland-Staerke GmbH
    Inventors: Martin Lotz, Gerold Eggengoor
  • Publication number: 20100323968
    Abstract: Processes for inhibiting apoptotic cell death and glycosaminoglycan release from injured cartilage is provided. Inhibition is accomplished using caspase inhibitors.
    Type: Application
    Filed: August 24, 2010
    Publication date: December 23, 2010
    Applicant: The Scripps Research Institute
    Inventors: Darryl D'Lima, Martin Lotz, Clifford Colwell
  • Publication number: 20100166939
    Abstract: The present invention relates to a process for preparing modified potato flakes or modified potato granules, comprising the steps of: a) washing potatoes; b) removing the peel and any impurities where applicable; c) optionally cutting the potatoes up; d) optionally blanching the potatoes; e) optionally cooling the potatoes if step d) is performed; f) cooking the potatoes under steam; g) sieving or pulping the potatoes cooked under steam; h) optionally adding additives other than fibrous materials; and i) drying the pulp obtained, wherein, after step b) and before step i), fibrous materials are added in at least one further step and are mixed substantially homogeneously into a product of the process as present at the time when they are added; modified potato flakes or potato granules prepared in accordance with said process, and their use.
    Type: Application
    Filed: April 25, 2008
    Publication date: July 1, 2010
    Inventors: Martin Lotz, Johannes B. Borghuis, Frank Schaiper, Christian Francke
  • Publication number: 20100063254
    Abstract: A process for producing coagulated leguminous protein fractions of MW>14, comprising: initial charging of fruit juice; coagulation of the leguminous protein; removal of a leguminous protein fraction whose majority has an MW of from >14 kD to approx. 600 kD; optionally, washing the coagulated leguminous protein fraction thus obtained; and optionally, drying the leguminous protein fraction, and to the use of the leguminous protein fraction as a food, food additive, medicament additive, animal feed, in cosmetics, as industrial protein, and/or as an adhesive.
    Type: Application
    Filed: September 24, 2007
    Publication date: March 11, 2010
    Applicant: EMSLAND-STAERKE GMBH
    Inventors: Martin Lotz, Gerold Eggengoor
  • Publication number: 20100048873
    Abstract: A method of preparing a coagulated plant protein fraction with a medium molecular weight of between 14 to 97, by providing fruit juice in aqueous solution; precipitating a high-molecular-weight plant protein fraction whose bulk has a molecular weight of from above 100 to 600, by adjusting an acidic pH and/or a temperature above room temperature, and mechanically separating the fraction precipitated thus; precipitating a medium-molecular-weight coagulated plant protein fraction under warm conditions by treating, at pH 2 to 7, and between 60 to 90° C., the solution obtained after separation of the high-molecular-weight plant protein fraction and mechanically separating the medium-molecular-weight coagulated plant protein fraction with a molecular weight of between approximately 14 to 97, with the bulk of the molecular weight distribution being between 20 to 60.
    Type: Application
    Filed: September 24, 2007
    Publication date: February 25, 2010
    Applicant: EMSLAND-STAERKE GMBH
    Inventors: Martin Lotz, Gerold Eggengoor
  • Publication number: 20090186827
    Abstract: Processes for inhibiting apoptotic cell death and glycosaminoglycan release from injured cartilage is provided. Inhibition is accomplished using caspase inhibitors.
    Type: Application
    Filed: July 22, 2008
    Publication date: July 23, 2009
    Applicant: The Scripps Research Institute
    Inventors: Darryl D'Lima, Martin Lotz, Clifford Colwell
  • Publication number: 20080226807
    Abstract: A method of preparing potato fibres includes the steps of: a) washing potatoes; b) optionally removing solid impurities and rinsing water adhering to the potatoes; c) grinding the potatoes into a pulp; d) separating potato fruit water; e) removing starch and optionally residual potato fruit water in order to obtain raw fibres; f) refining the raw fibres; g) mixing in potato fibres which have previously been dried; and h) drying the fibres; as well as potato fibres obtainable by that method and use thereof.
    Type: Application
    Filed: March 10, 2008
    Publication date: September 18, 2008
    Applicant: EMSLAND STARKE GMBH
    Inventors: Martin Lotz, Martin Jahn, Paul Buntrock, Gerold Eggengoor
  • Publication number: 20080226781
    Abstract: A method of obtaining vegetable proteins and/or peptides is disclosed that includes the steps of: a) preparing a vegetable starting material containing proteins and/or peptides in an aqueous matrix; b) optionally eliminating solid components from said aqueous matrix and/or clarifying said aqueous matrix; c) isolating the proteins and/or peptides from the aqueous matrix by adsorption on at least one ion exchanger membrane made of a synthetic polymer; d) optionally rinsing the ion exchanger membrane in order to remove impurities; e) desorbing the proteins and/or peptides from the ion exchanger membrane with at least one eluent; f) isolating the proteins and/or peptides from the eluent; and g) optionally drying the isolated proteins and/or peptides; and a protein, peptide and/or mixtures thereof prepared in accordance with the method, and uses thereof.
    Type: Application
    Filed: March 10, 2008
    Publication date: September 18, 2008
    Applicant: EMSLAND-STARKE GMBH
    Inventors: Martin Lotz, Gerold Eggengoor
  • Patent number: 7411000
    Abstract: Processes for inhibiting apoptotic cell death and glycosaminoglycan release from injured cartilage is provided. Inhibition is accomplished using caspase inhibitors.
    Type: Grant
    Filed: March 15, 2002
    Date of Patent: August 12, 2008
    Assignee: The Scripps Research Institute
    Inventors: Darryl D'Lima, Martin Lotz, Clifford Colwell
  • Publication number: 20020183258
    Abstract: Processes for inhibiting apoptotic cell death and glycosaminoglycan release from injured cartilage is provided. Inhibition is accomplished using caspase inhibitors.
    Type: Application
    Filed: March 15, 2002
    Publication date: December 5, 2002
    Applicant: The Scripps Research Institute
    Inventors: Darryl D'Lima, Martin Lotz, Clifford Colwell
  • Patent number: 5271931
    Abstract: The present invention relates to the use of interferon and/or interleukin-6 to increase intravascular C1 inhibitor concentrations in patients exhibiting or at risk for a C1 inhibitor deficiency. Therapeutic compositions containing interferon and/or interleukin-6 are also disclosed.
    Type: Grant
    Filed: September 14, 1988
    Date of Patent: December 21, 1993
    Assignee: The Scripps Research Institute
    Inventors: Martin Lotz, Bruce Zuraw, Dennis A. Carson